Aspiriant LLC’s iShares iBoxx $ Investment Grade Corporate Bond ETF LQD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Sell
10,651
-167
-2% -$18.4K 0.03% 145
2025
Q4
$1.19M Sell
10,818
-112
-1% -$12.5K 0.03% 150
2025
Q3
$1.22M Sell
10,930
-10,696
-49% -$1.18M 0.04% 132
2025
Q2
$2.37M Buy
+21,626
New +$2.32M 0.08% 92
2022
Q1
Sell
-1,979
Closed -$263K 289
2021
Q4
$263K Buy
+1,979
New +$263K 0.01% 242
2021
Q1
Sell
-18,480
Closed -$2.55M 205
2020
Q4
$2.55M Hold
18,480
0.17% 56
2020
Q3
$2.49M Buy
+18,480
New +$2.52M 0.19% 59
2017
Q4
Sell
-1,702
Closed -$206K 133
2017
Q3
$206K Buy
1,702
+1
+0.1% +$121 0.02% 193
2017
Q2
$205K Sell
1,701
-299
-15% -$35.7K 0.02% 199
2017
Q1
$236K Buy
+2,000
New +$235K 0.02% 190

Other funds holding LQD

Aspiriant LLC's LQD Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) stake by 1.5% in Q1 2026, selling an estimated $18.4K and leaving 10,651 shares worth $1.16M. The position accounts for 0.03% of the portfolio, ranked #145.

Aspiriant LLC first reported a position in LQD in Q1 2017 and has held it in 10 quarters since. The position peaked at $2.55M in Q4 2020. 1,095 funds tracked by Wall St. Rank hold LQD as of Q1 2026.

  • Aspiriant LLC held 10,651 shares of iShares iBoxx $ Investment Grade Corporate Bond ETF worth $1.16M as of Q1 2026.
  • Aspiriant LLC sold 167 iShares iBoxx $ Investment Grade Corporate Bond ETF shares in Q1 2026, an estimated $18.4K.
  • iShares iBoxx $ Investment Grade Corporate Bond ETF made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #145 holding.
  • Aspiriant LLC first reported a position in iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2017 and has held it in 10 quarters since.
  • Aspiriant LLC's iShares iBoxx $ Investment Grade Corporate Bond ETF position peaked at $2.55M in Q4 2020.
  • 1,095 funds tracked by Wall St. Rank held iShares iBoxx $ Investment Grade Corporate Bond ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.